Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 64 Colonic Neoplasms 19 Rectal Neoplasms 12 Esophageal Neoplasms 9 Neoplasms 8 Neoplasm Metastasis 8 Cholangiocarcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 6 Breast Neoplasms 6 Colorectal Cancer Metastatic 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 4 Ovarian Neoplasms 3 Inflammatory Breast Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Glioma 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Biliary Tract Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oesophago-gastric Cancer × Panitumumab × Clear all

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡